RxDoctor Payments Data

Steven Raible, MD

Cardiovascular Disease · Louisville, KYNPI 1700861432

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Heartflow, Inc. accounts for 71.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $22,467 and has fallen 99.3% since, to $168 in 2025. Among cardiovascular disease clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,050in general payments, 2019–2025

Across 145 payments — averaging $207.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Heartflow, Inc.$22K
  • Boston Scientific$4K
  • GE HealthCare$2K
  • Edwards Lifesciences$1K
  • Amgen$336
  • Astellas Pharma US Inc$280
  • plus $1K from 12 others
$9,415in research payments, 2019–2025

Across 4 payments — averaging $2353.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Heartflow, Inc.$9K

What the payments were for

  • Consulting fees$16,00253%
  • Travel & lodging$5,85719%
  • Food & beverage$7,90326%
  • Education$2881%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,050 in reported general payments places this provider in the 90th percentile of 258 cardiovascular disease providers in Kentucky.

See all cardiovascular disease providers in Kentucky

Medicare billing

Part B allowed, 2024
$14,845
Medicare patients
148
Services billed
195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →